These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A review of the therapeutic efficacy of misoprostol, a prostaglandin E1 analogue. Nicholson PA S Afr Med J; 1988 Jul; 74 Suppl():56-8. PubMed ID: 3133797 [No Abstract] [Full Text] [Related]
23. Is a pound of prevention worth an ounce of cure? Fennerty MB Gastroenterology; 1996 Mar; 110(3):958-60. PubMed ID: 8608912 [No Abstract] [Full Text] [Related]
24. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G; Lazzaroni M; Petrillo M Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319 [TBL] [Abstract][Full Text] [Related]
25. Economic evaluation of prophylactic treatment with Misoprostol in osteoarthritic patients treated with NSAIDs. The case of Belgium. Carrin GJ; Torfs KE Rev Epidemiol Sante Publique; 1990; 38(3):187-99. PubMed ID: 2118670 [TBL] [Abstract][Full Text] [Related]
26. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. Hillman AL; Bloom BS Arch Intern Med; 1989 Sep; 149(9):2061-5. PubMed ID: 2505706 [TBL] [Abstract][Full Text] [Related]
27. Prevention of gastroduodenal injury induced by NSAIDs with low-dose misoprostol. Medina Santillán R; Reyes García G; Mateos García E Proc West Pharmacol Soc; 1999; 42():33-4. PubMed ID: 10697681 [No Abstract] [Full Text] [Related]
33. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study. Jiranek GC; Kimmey MB; Saunders DR; Willson RA; Shanahan W; Silverstein FE Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):656-61. PubMed ID: 2491827 [TBL] [Abstract][Full Text] [Related]
34. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Lanza FL; Aspinall RL; Swabb EA; Davis RE; Rack MF; Rubin A Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266 [TBL] [Abstract][Full Text] [Related]
35. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. Koch M; Dezi A; Ferrario F; Capurso I Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239 [TBL] [Abstract][Full Text] [Related]
37. Preventing NSAID-induced ulcers: the use of misoprostol. Lynn MM; Holdcroft C Nurse Pract; 1990 Oct; 15(10):38-9, 42. PubMed ID: 2122334 [No Abstract] [Full Text] [Related]
38. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484 [TBL] [Abstract][Full Text] [Related]
39. Prevention of NSAID-induced ulcers in the elderly. Geriatrics; 2005 Oct; Suppl():3-12; quiz 13-4. PubMed ID: 16334635 [No Abstract] [Full Text] [Related]
40. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions. Davis R; Yarker YE; Goa KL Drugs Aging; 1995 Nov; 7(5):372-93. PubMed ID: 8573992 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]